ProCE Banner Activity

Understanding the Updated WHO Guidelines for Chronic HBV Infection

Clinical Thought

The updated World Health Organization guidelines for chronic hepatitis B virus (HBV) infection expand the criteria for treatment eligibility, but what does that really mean in practice? In this ClinicalThought commentary, learn how an expert utilizes the updated guidelines to improve outcomes for people with chronic HBV infection.

Released: June 12, 2024

Expiration: June 11, 2025

Share

Faculty

Paul Y. Kwo

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Paul Y. Kwo, MD: consultant/advisor: Aligos, Drug Farm, Eiger, Galapagos, Gilead, HEPQuant, Inventiva, Mallinckrodt, Mirum, Surrozen; researcher: Altimmune, Eiger, Gilead, Novo Nordisk; individual publicly traded stocks/stock options: Durect.